Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Inflammation 3Vasculitis 2Uveitis 2Granulomatosis with Polyangiitis 2Arthritis, Juvenile 2Temporomandibular Joint Disorders 1Stomatitis 1Pneumonia 1Neoplasms 1Metabolic Syndrome 1Lupus Nephritis 1Asthma 1Arthritis, Rheumatoid 1

Interventions

Pioglitazone 1Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Metabolic Syndrome × Etanercept × Clear all
NCT00111956 2017-10-06

Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 2/3 Completed
56 enrolled

Inflammation, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡